chr1-160347231-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015331.3(NCSTN):​c.191-1768C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.432 in 152,028 control chromosomes in the GnomAD database, including 15,147 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 15147 hom., cov: 32)

Consequence

NCSTN
NM_015331.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0920

Publications

14 publications found
Variant links:
Genes affected
NCSTN (HGNC:17091): (nicastrin) This gene encodes a type I transmembrane glycoprotein that is an integral component of the multimeric gamma-secretase complex. The encoded protein cleaves integral membrane proteins, including Notch receptors and beta-amyloid precursor protein, and may be a stabilizing cofactor required for gamma-secretase complex assembly. The cleavage of beta-amyloid precursor protein yields amyloid beta peptide, the main component of the neuritic plaque and the hallmark lesion in the brains of patients with Alzheimer's disease; however, the nature of the encoded protein's role in Alzheimer's disease is not known for certain. Mutations in this gene are associated with familial acne inversa. A pseudogene of this gene is present on chromosome 21. Alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Feb 2014]
NCSTN Gene-Disease associations (from GenCC):
  • acne inversa, familial, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.593 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015331.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NCSTN
NM_015331.3
MANE Select
c.191-1768C>T
intron
N/ANP_056146.1
NCSTN
NM_001290184.2
c.131-1768C>T
intron
N/ANP_001277113.1
NCSTN
NM_001349729.2
c.191-1768C>T
intron
N/ANP_001336658.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NCSTN
ENST00000294785.10
TSL:1 MANE Select
c.191-1768C>T
intron
N/AENSP00000294785.5
NCSTN
ENST00000368063.6
TSL:1
n.*120-1768C>T
intron
N/AENSP00000357042.2
NCSTN
ENST00000699555.1
n.512C>T
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.432
AC:
65601
AN:
151908
Hom.:
15150
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.536
Gnomad AMR
AF:
0.475
Gnomad ASJ
AF:
0.440
Gnomad EAS
AF:
0.343
Gnomad SAS
AF:
0.612
Gnomad FIN
AF:
0.501
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.508
Gnomad OTH
AF:
0.466
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.432
AC:
65623
AN:
152028
Hom.:
15147
Cov.:
32
AF XY:
0.434
AC XY:
32231
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.257
AC:
10672
AN:
41452
American (AMR)
AF:
0.475
AC:
7255
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.440
AC:
1527
AN:
3470
East Asian (EAS)
AF:
0.343
AC:
1774
AN:
5172
South Asian (SAS)
AF:
0.611
AC:
2944
AN:
4818
European-Finnish (FIN)
AF:
0.501
AC:
5289
AN:
10558
Middle Eastern (MID)
AF:
0.548
AC:
161
AN:
294
European-Non Finnish (NFE)
AF:
0.508
AC:
34531
AN:
67964
Other (OTH)
AF:
0.466
AC:
983
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1860
3720
5579
7439
9299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
622
1244
1866
2488
3110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.331
Hom.:
1062
Bravo
AF:
0.422
Asia WGS
AF:
0.473
AC:
1644
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.3
DANN
Benign
0.75
PhyloP100
-0.092
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6668576; hg19: chr1-160317021; API